标题
The determination and interpretation of the therapeutic index in drug development
作者
关键词
-
出版物
NATURE REVIEWS DRUG DISCOVERY
Volume 11, Issue 10, Pages 751-761
出版商
Springer Nature
发表日期
2012-08-31
DOI
10.1038/nrd3801
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- In silicomodels for drug-induced liver injury – current status
- (2012) Katarzyna R Przybylak et al. Expert Opinion on Drug Metabolism & Toxicology
- Proteomics in the search for mechanisms and biomarkers of drug-induced hepatotoxicity
- (2012) Anke Van Summeren et al. TOXICOLOGY IN VITRO
- α4β2 neuronal nicotinic receptor positive allosteric modulation: An approach for improving the therapeutic index of α4β2 nAChR agonists in pain
- (2011) Chih-Hung Lee et al. BIOCHEMICAL PHARMACOLOGY
- On the relationship between block of the cardiac Na+channel and drug-induced prolongation of the QRS complex
- (2011) AR Harmer et al. BRITISH JOURNAL OF PHARMACOLOGY
- Drug Safety Sciences and the Bottleneck in Drug Development
- (2011) P B Watkins CLINICAL PHARMACOLOGY & THERAPEUTICS
- Imatinib mesylate for the treatment of pulmonary arterial hypertension
- (2011) Henrik ten Freyhaus et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Managing the challenge of chemically reactive metabolites in drug development
- (2011) B. Kevin Park et al. NATURE REVIEWS DRUG DISCOVERY
- Comparative requirements for exploratory clinical trials — eIND, eCTA and microdosing
- (2010) Patrick Y. Muller ADVANCED DRUG DELIVERY REVIEWS
- Permitting Product Liability Litigation for FDA-Approved Drugs and Devices Promotes Patient Safety
- (2010) A S Kesselheim CLINICAL PHARMACOLOGY & THERAPEUTICS
- Native albumin for targeted drug delivery
- (2010) Elena Neumann et al. Expert Opinion on Drug Delivery
- The effect of plasma protein binding on in vivo efficacy: misconceptions in drug discovery
- (2010) Dennis A. Smith et al. NATURE REVIEWS DRUG DISCOVERY
- Membrane transporters in drug development
- (2010) NATURE REVIEWS DRUG DISCOVERY
- Use of transcriptomics in understanding mechanisms of drug-induced toxicity
- (2010) Yuxia Cui et al. PHARMACOGENOMICS
- The use of Cav rather than AUC in safety assessment
- (2010) D.A. Smith et al. REGULATORY TOXICOLOGY AND PHARMACOLOGY
- Autoradiography, MALDI-MS, and SIMS-MS Imaging in Pharmaceutical Discovery and Development
- (2009) Eric G. Solon et al. AAPS Journal
- Safety Assessment and Dose Selection for First-in-Human Clinical Trials With Immunomodulatory Monoclonal Antibodies
- (2009) PY Muller et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- The minimum anticipated biological effect level (MABEL) for selection of first human dose in clinical trials with monoclonal antibodies
- (2009) Patrick Y Muller et al. CURRENT OPINION IN BIOTECHNOLOGY
- Genomic and proteomic approaches for predicting toxicity and adverse drug reactions
- (2009) Feng Ge et al. Expert Opinion on Drug Metabolism & Toxicology
- Tissue-specific, non-invasive toxicity biomarkers: translation from preclinical safety assessment to clinical safety monitoring
- (2009) Patrick Y Muller et al. Expert Opinion on Drug Metabolism & Toxicology
- In vitrosafety pharmacology profiling: what else beyond hERG?
- (2009) Jacques Hamon et al. Future Medicinal Chemistry
- Concentration-dependent plasma protein binding of the novel dipeptidyl peptidase 4 inhibitor BI 1356 due to saturable binding to its target in plasma of mice, rats and humans
- (2009) Holger Fuchs et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Translation between in vitro inhibition of the cardiac Nav1.5 channel and pre-clinical and clinical QRS widening
- (2009) Jason Cordes et al. JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation